HUTCHMED (China) Limited
HCMNASDAQHealthcare● Active
$10.85
$-0.02(-0.18%)
Market Cap$1.9B
P/E Ratio—
52W High$19.5
52W Low$10.73
HUTCHMED (China) Limited (HCM) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · HCM · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.55B | $0.63B | $0.84B | $0.43B | $0.36B |
| Cost of Revenue | $0.34B | $0.35B | $0.38B | $0.31B | $0.26B |
| Gross Profit | $0.21B | $0.28B | $0.45B | $0.12B | $0.10B |
| Gross Margin %(computed) | 38.68% | 44.64% | 54.12% | 27.04% | 27.49% |
| Operating Expenses | |||||
| R&D Expenses | $0.16B | $0.21B | $0.30B | $0.27B | $0.21B |
| G&A Expenses | $0.00B | $0.06B | $0.08B | $0.09B | $0.09B |
| Total Operating Expenses | $0.27B | $0.32B | $0.44B | $0.52B | $0.43B |
| Operating Income | ($0.05B) | ($0.04B) | $0.02B | ($0.41B) | ($0.33B) |
| Operating Margin %(computed) | -9.95% | -6.94% | 2.19% | -96.10% | -92.19% |
| Interest Income | $0.05B | $0.04B | $0.04B | $0.01B | $0.00B |
| Interest Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Income Before Tax | $0.52B | $0.05B | $0.11B | ($0.36B) | ($0.16B) |
| Income Tax Expense | $0.06B | $0.01B | $0.00B | ($0.00B) | $0.01B |
| Net Income | $0.46B | $0.04B | $0.10B | ($0.36B) | ($0.19B) |
| Net Margin %(computed) | 83.30% | 5.99% | 12.03% | -84.62% | -54.66% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $2.65 | $0.22 | $0.60 | $-2.15 | $-1.25 |
| Wtd Avg Shares | 0.17B | 0.17B | 0.17B | 0.17B | 0.16B |
| EBITDA | ($0.04B) | ($0.03B) | $0.03B | ($0.40B) | ($0.21B) |
| EBITDA Margin %(computed) | -7.52% | -4.98% | 3.17% | -94.07% | -58.39% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · B
Explore more HUTCHMED (China) Limited data
About HUTCHMED (China) Limited (HCM) Income Statement
HUTCHMED (China) Limited (HCM) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, HCM reported revenue of $0.55B, gross profit of $0.21B (gross margin 38.68%), and net income of $0.46B — a net profit margin of 83.30%.
Frequently asked questions
HCM · 4 questionsHUTCHMED (China) Limited (HCM) reported revenue of $0.55B for 2025, down 12.7% year-over-year.
HCM revenueHCM salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08